Sort
40,608 grants matching “prostate cancer”
Functional Analysis of Distinct and Co-existing Transcriptional Programs Regulating Tumor Dormancy
$384,300Maria Sosa · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Functional Analysis of Distinct and Co-existing Transcriptional Programs Regulating Tumor Dormancy
$384,300Maria Sosa · Albert Einstein College Of Medicine · R01 · FY2025 · CA
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
$384,283Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2022 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$384,278Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2023 · CA
Hyperpolarized 13c NMR Studies of Prostate Cancer (RMI)
$384,258John Kurhanewicz · University Of California, San Francisco · R21 · FY2007 · EB
Targeting cytoplasmic SET oncoprotein by sphingolipid analog drugs for the induction of necroptosis to treat lung cancer
$384,227Besim Ogretmen · Medical University Of South Carolina · R01 · FY2024 · CA
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
$384,136Yan Xu · Indiana University Indianapolis · R01 · FY2013 · CA
Transcription Dynamics in Single Cells
$384,127Daniel Larson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
$384,109Sheila H Ridner · Vanderbilt University · R01 · FY2013 · CA
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
$384,104Scott D Cramer · University Of Colorado Denver · R01 · FY2023 · CA
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
$384,104Scott D Cramer · University Of Colorado Denver · R01 · FY2022 · CA
GENE-ENVIRONMENT INTERACTION IN PROSTATE CANCER
$384,097Henry Ford Health System · R01 · FY2002 · ES
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$384,048Joel H Saltz · State University New York Stony Brook · UG3 · FY2019 · CA
Macrophages induce a tumor-promoting stable EMT in prostate cancer
$384,035Kenneth J. Pienta · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
IGF-I LEVELS, IGF-I GENOTYPE, AND PROSTATE CANCER
$384,028Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
Targeting Drug-Resistant Castration Resistant Prostate Cancer via LIMK2
$384,026Kavita Shah · Purdue University · R01 · FY2023 · CA
ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE
$383,993University Of Southern California · R01 · FY2000 · CA
Phase I Clinical Trials of Novel Agents
$383,985Sloan-Kettering Institute For Cancer Res · U01 · FY2003 · CA
Reduced-Order Constrained Optimization for Rapid IMRT and VMAT Treatment Planning
$383,930Richard J Radke · Rensselaer Polytechnic Institute · R01 · FY2012 · CA
Characterizing the signaling pathways that regulate Skp2 oncogenic function
$383,865Wenyi Wei · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Pure Flavonolignans from S. marianum in Prostate Cancer
$383,850David J Kroll · Research Triangle Institute · R01 · FY2006 · CA
Requirements for Normal Rb Function In Vivo
$383,842David W Goodrich · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$383,837Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2014 · NR
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
$383,789David Gius · University Of Texas Hlth Science Center · R01 · FY2025 · CA